Lemaitre Vascular (LMAT) Tops Q1 EPS by 2c; Guides Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
LeMaitre Q1 2023 Financial Results
May 2, 2023 4:05 PM EDTBURLINGTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q1 2023 results, announced a $0.14/share quarterly dividend and provided guidance.
Q1 2023 Financial ResultsÂ
Sales $47.1mm, +19% (+22% organic) vs. Q1 2022Op. income $7.9mm, -1%Op. margin 17%Net income $6.0mm, flatEarnings per diluted share $0.27, -1%Valvulotomes (+29%), carotid patches (+17%), bovine grafts (+22%), allografts (+42%) and... More
